等待開盤 09-24 09:30:00 美东时间
-0.210
-0.77%
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Evercore ISI Group analyst Michael Griffin upgraded Macerich Co (NYSE:MAC) from In-Line to Outper...
09-21 20:17
今日重点评级关注:Canaccord Genuity:维持Generac Holdings"买入"评级,目标价从275美元升至375美元;巴克莱:维持Oscar Health"超配"评级,目标价从39美元升至49美元
09-18 16:18
REIT investors are finding opportunities in property sectors tied to demographic and housing trends, although some areas remain more challenging as financing costs stay elevated. David Auerbach of Hoy...
09-18 00:53
Scotiabank analyst Nicholas Yulico maintains Invitation Homes (NYSE:INVH) with a Sector Perform and lowers the price target from $30 to $28.
09-17 23:44
Invitation Homes (INVH) declares $0.30/share quarterly dividend, in line with previous. Forward yield 4.35% Payable Oct. 16; for shareholders of record Sept. 24; ex-div Sept. 24. See INVH Dividend Sco...
09-11 18:49
今日重点评级关注:摩根大通:维持Ultragenyx Pharmaceutical"超配"评级,目标价从75美元升至80美元;瑞杰金融:维持英伟达"强力买入"评级,目标价从330美元升至352美元
08-26 08:37
JP Morgan analyst Anthony Paolone maintains Invitation Homes (NYSE:INVH) with a Overweight and raises the price target from $33 to $34.
08-25 20:47
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45